Differences between natural and recombinant G protein-coupled receptor systems with varying receptor/G protein stoichiometry.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  TIPS - Trends in Pharmacological Sciences

• Publication date

  1997-12-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0165-6147(97)01136-XPMID 9458693
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Protean Agonists

  1997cited by this paper
• Expression cloning and receptor pharmacology of human calcitonin receptors from MCF-7 cells and their relationship to amylin receptors.

  1997cited by this paper
• Do Recombinant Receptor Assays Provide Affinity and Provide Estimates?

  1997cited by this paper
• Agonist Efficacy and Aliosteric Models of Receptor Action a

  1997cited by this paper
• The stability of the agonist beta2-adrenergic receptor-Gs complex: evidence for agonist-specific states.

  1997cited by this paper
• Do recombinant receptor assays provide affinity and potency estimates?

  1997cited by this paper
• Agonist-induced modulation of inverse agonist efficacy at the beta 2-adrenergic receptor.

  1996cited by this paper
• RECEPTOR CONFORMATIONAL INDUCTION VERSUS SELECTION : ALL PART OF THE SAME ENERGY LANDSCAPE

  1996cited by this paper
• THE CUBIC TERNARY COMPLEX RECEPTOR-OCCUPANCY MODEL. II. UNDERSTANDING APPARENT AFFINITY

  1996cited by this paper
• Radiolabelling of the human 5-HT2A receptor with an agonist, a partial agonist and an antagonist: effects on apparent agonist affinities.

  1996cited by this paper
• The Cubic Ternary Complex ReceptorOccupancy Model I. Model Description

  1996cited by this paper
• Agonist-receptor efficacy. II. Agonist trafficking of receptor signals.

  1995cited by this paper
• Density of alpha-2A adrenoceptors and Gi proteins in the human brain: ratio of high-affinity agonist sites to antagonist sites and effect of age.

  1994cited by this paper
• Dual signaling potential is common among Gs-coupled receptors and dependent on receptor density.

  1994cited by this paper
• Molecular cloning and expression of a cDNA encoding the secretin receptor.

  1991cited by this paper
• Do pharmacological methods for the quantification of agonists work when the ternary complex mechanism operates?

  1989cited by this paper
• Continuous variation of agonist affinity constants.

  1988cited by this paper
• Perspectives on receptor classification

  1987cited by this paper
• A Pharmacologic Analysis of Drug-Receptor Interaction

  1987cited by this paper
• Imprecision in presentation of binding studies

  1985cited by this paper

• Agonism and Biased Signaling.

  2025cites this paper
• The complex molecular pharmacology of the dopamine D2 receptor: Implications for pramipexole, ropinirole, and rotigotine.

  2023cites this paper
• Importance of receptor expression in the classification of novel ligands at the M2 muscarinic acetylcholine receptor

  2022cites this paper
• Pharmacological characterization of novel synthetic opioids: Isotonitazene, metonitazene, and piperidylthiambutene as potent MU opioid receptor agonists.

  2022cites this paper
• Dopamine D2L receptor density influences the recruitment of β-arrestin2 and Gi1 induced by antiparkinsonian drugs.

  2022cites this paper
• Community guidelines for GPCR ligand bias: IUPHAR review 32

  2022cites this paper
• Prostaglandin F2α and angiotensin II type 1 receptors exhibit differential cognate G protein coupling regulation

  2022cites this paper
• Application of Alanine Scanning to Determination of Amino Acids Essential for Peptide Adsorption at the Solid/Solution Interface and Binding to the Receptor: Surface-Enhanced Raman/Infrared Spectroscopy versus Bioactivity Assays

  2021cites this paper
• Endogenous Mas‐related G‐protein‐coupled receptor X1 activates and sensitizes TRPA1 in a human model of peripheral nerves

  2021cites this paper
• BRET Analysis of GPCR Dimers in Neurons and Non-Neuronal Cells: Evidence for Inactive, Agonist, and Constitutive Conformations

  2021cites this paper
• Cellular and Molecular Mechanisms of Fat Taste Perception.

  2021cites this paper
• International Union of Basic and Clinical Pharmacology. Recommendations for GPCR ligand bias

  2021cites this paper
• Shuttling of Peptide‐Drug Conjugates by G Protein‐Coupled Receptors Is Significantly Improved by Pulsed Application

  2020cites this paper
• Agonists

  2019cites this paper
• Biased Receptor Signaling in Drug Discovery

  2019influential citation
• The nature of efficacy at G protein-coupled receptors.

  2019cites this paper
• Ligand binding and activation of UTP-activated G protein-coupled P2Y2 and P2Y4 receptors elucidated by mutagenesis, pharmacological and computational studies.

  2019cites this paper
• The PAR2 signal peptide prevents premature receptor cleavage and activation

  2019cites this paper
• How Different Tissues Process Drug Response

  2019cites this paper
• Synthesis and Pharmacological Evaluation of 1-Phenyl-3-Thiophenylurea Derivatives as Cannabinoid Type-1 Receptor Allosteric Modulators.

  2019cites this paper
• Free fatty acid receptor 1 ( FFA 1 R / GPR 40 ) and its involvement in fatty-acid-stimulated insulin secretion

  2018cites this paper
• Invertebrate serotonin receptors: a molecular perspective on classification and pharmacology

  2018cites this paper
• Evaluation of agonist and antagonist radioligands for somatostatin receptor imaging of breast cancer using positron emission tomography

  2017cites this paper
• Molecular Recognition of Agonists and Antagonists by the Nucleotide-Activated G Protein-Coupled P2Y2 Receptor.

  2017cites this paper
• G protein stoichiometry dictates biased agonism through distinct receptor-G protein partitioning

  2017cites this paper
• A1 adenosine receptor attenuates intracerebral hemorrhage-induced secondary brain injury in rats by activating the P38-MAPKAP2-Hsp27 pathway

  2016cites this paper
• Over-expression of V1A receptors in PVN modulates autonomic cardiovascular control.

  2016cites this paper
• GPR142 Agonists Stimulate Glucose-Dependent Insulin Secretion via Gq-Dependent Signaling

  2016cites this paper
• Delineating biased ligand efficacy at 7TM receptors from an experimental perspective.

  2016cites this paper
• Tactical Approaches to Interconverting GPCR Agonists and Antagonists.

  2016cites this paper
• Signaling switch of the urotensin II vasosactive peptide GPCR: prototypic chemotaxic mechanism in glioma

  2015cites this paper
• The role of endocannabinoids and their receptors on the regulation of bladder function and detrusor overactivity

  2015cites this paper
• Use of radiolabeled antagonist assays for assessing agonism at D2 and D3 dopamine receptors: comparison with functional GTPγS assays.

  2015cites this paper
• The Structural Basis of Gβ5-RGS7 Interaction with the Muscarinic M3 Receptor and Implications for its Role in Functional Pathway Selectivity

  2014cites this paper
• Pharmacology and Signaling of MAS-Related G Protein–Coupled Receptors

  2014cites this paper
• Signalling properties and pharmacology of a 5‐HT7‐type serotonin receptor from Tribolium castaneum

  2014cites this paper
• Extracellular Loop II Modulates GTP Sensitivity of the Prostaglandin EP3 Receptor

  2013cites this paper
• Development of novel cellular model for affinity studies of histamine H(4) receptor ligands.

  2013cites this paper
• Cellular Mechanisms of Nociceptin/Orphanin FQ (N/OFQ) Peptide (NOP) Receptor Regulation and Heterologous Regulation by N/OFQ

  2013cites this paper
• True wild type and recombinant wild type cytochrome c oxidase from Paracoccus denitrificans show a 20-fold difference in their catalase activity.

  2013cites this paper
• Human induced pluripotent stem cells and their use in drug discovery for toxicity testing.

  2013cites this paper
• Cell type influences the molecular mechanisms involved in hormonal regulation of ERG K+ channels

  2012cites this paper
• The Pharmacology of Functional, Biochemical, and Recombinant Receptor Systems

  2012cites this paper
• Increasing the density of the D2L receptor and manipulating the receptor environment are required to evidence the partial agonist properties of aripiprazole.

  2012cites this paper
• Agonist high- and low-affinity states of dopamine D2 receptors: methods of detection and clinical implications

  2012cites this paper
• Deorphanization of biogenic amine-responsive G protein-coupled receptors in various model protozoa and platyhelminthes

  2012cites this paper
• Leukotriene receptors.

  2011cites this paper
• Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases.

  2011cites this paper
• ET-1 induced Elevation of intracellular calcium in clonal neuronal and embryonic kidney cells involves endogenous endothelin-A receptors linked to phospholipase C through Gα(q/11).

  2011cites this paper
• Impact of fusion to Gαi2 and co‐expression with RGS proteins on pharmacological properties of human cannabinoid receptors CB1R and CB2R

  2011cites this paper
• International Union of Basic and Clinical Pharmacology. LXXXIV: Leukotriene Receptor Nomenclature, Distribution, and Pathophysiological Functions

  2011influential citation
• The design, synthesis and pharmacological characterization of novel β2‐adrenoceptor antagonists

  2011cites this paper
• Endothelin type B receptor-induced sustained Ca2+ influx involves G(q/11)/phospholipase C-independent, p38 mitogen-activated protein kinase-dependent activation of Na+/H+ exchanger.

  2010cites this paper
• Cysteinyl Leukotrienes and Their Receptors: Molecular and Functional Characteristics

  2010cites this paper
• Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery

  2010cites this paper
• The GTPase assay as a highly sensitive model system for characterization of human cannabinoid receptors and their ligands. G alpha i2 co-expression and fusion studies and the impact of RGS proteins

  2010cites this paper
• High‐Throughput GPCR Screening Technologies and the Emerging Importance of the Cell Phenotype

  2010cites this paper
• Label-free whole-cell assays: expanding the scope of GPCR screening.

  2010cites this paper
• Molecular analysis of the histamine H3-receptor

  2010cites this paper
• Biphasic suppression of appetite by cannabinoid CB1 receptor antagonists with distinct functional activities.

  2010cites this paper
• D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]‐MNPA, [3H]‐(+)‐PHNO, and [3H]‐raclopride

  2010cites this paper
• Investigating Allosteric Activation of the M1 Muscarinic Acetylcholine Receptor

  2010cites this paper
• No Evidence for Functional Selectivity of Proxyfan at the Human Histamine H3 Receptor Coupled to Defined Gi/Go Protein Heterotrimers

  2010cites this paper
• Chapter 2 – How Different Tissues Process Drug Response

  2009cites this paper
• Dopamine D 2 / 3 Receptor Occupancy of Apomorphine in the Nonhuman Primate Brain — A Comparative PET Study With [ 11 C ] Raclopride and [ 11 C ] MNPA

  2009cites this paper
• Target site occupancy: emerging generalizations from clinical and preclinical studies.

  2009cites this paper
• The action of xanomeline on human muscarinic receptors expressed in Chinese hamster ovary cells

  2009influential citation
• Dopamine D2/3 receptor occupancy of apomorphine in the nonhuman primate brain—A comparative PET study with [11C]raclopride and [11C]MNPA

  2009cites this paper
• Key determinants of nucleotide-activated G protein-coupled P2Y(2) receptor function revealed by chemical and pharmacological experiments, mutagenesis and homology modeling.

  2009cites this paper
• Evaluating Cellular Impedance Assays for Detection of GPCR Pleiotropic Signaling and Functional Selectivity

  2009cites this paper
• Non-linear mixed-effects modeling for complex biopharmaceutical data

  2009cites this paper
• Comparaison des mécanismes de régulation des isoformes a et b des récepteurs 5-HT4

  2009cites this paper
• Differential coupling of human endothelin type A receptor to G(q/11) and G(12) proteins: the functional significance of receptor expression level in generating multiple receptor signaling.

  2009cites this paper
• A Hematopoietic Perspective on the Promiscuity and Specificity of Gα16 Signaling

  2009cites this paper
• Membrane cholesterol depletion enhances ligand binding function of human serotonin1A receptors in neuronal cells.

  2009cites this paper
• Expression, binding, and signaling properties of CRF2(a) receptors endogenously expressed in human retinoblastoma Y79 cells: passage‐dependent regulation of functional receptors

  2008cites this paper
• Galpha-subunits differentially alter the conformation and agonist affinity of kappa-opioid receptors.

  2008cites this paper
• A perspective on more effective GPCR-targeted drug discovery efforts

  2008cites this paper
• A critical evaluation of adenosine A2A receptors as potentially "druggable" targets in Huntington's disease.

  2008cites this paper
• List of Tables vi List of Figures viii List of Abbreviations ix

  2008cites this paper
• INVOLVEMENT OF LIPID RAFTS IN G PROTEIN-COUPLED MONOAMINE RECEPTOR TRAFFICKING AND SIGNALING - A PHARMACOLOGICAL APPROACH

  2008cites this paper
• Molecular mechanisms that control initiation and termination of physiological depolarization-evoked transmitter release

  2008cites this paper
• Cat Iris Sphincter Smooth-Muscle Contraction: Comparison of FP-Class Prostaglandin Analog Agonist Activities

  2008cites this paper
• Electrophysiology-based analysis of human histamine H(4) receptor pharmacology using GIRK channel coupling in Xenopus oocytes.

  2008influential citation
• The use of immortalized cell lines in GPCR screening: the good, bad and ugly.

  2008cites this paper
• Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.

  2008cites this paper
• Label-free cell-based assays for GPCR screening.

  2008cites this paper
• Inhibition of 5‐HT1A receptor‐dependent cell survival by cAMP/protein kinase A: Role of protein phosphatase 2A and Bax

  2008cites this paper
• Co‐expression of mu and delta opioid receptors as receptor‐G protein fusions enhances both mu and delta signalling via distinct mechanisms

  2008cites this paper
• The Free Fatty Acid Receptor GPR40 - expression and role in islet hormone secretion

  2007cites this paper
• Both Ligand- and Cell-Specific Parameters Control Ligand Agonism in a Kinetic Model of G Protein–Coupled Receptor Signaling

  2007cites this paper
• Metabotropic GABA Receptors

  2007cites this paper
• The G protein-coupling specificity of D2-like dopamine receptors

  2007cites this paper
• Cysteinyl‐leukotrienes and their receptors in asthma and other inflammatory diseases: Critical update and emerging trends

  2007cites this paper
• Solubilization of human serotonin 1A receptors expressed in neuronal cells.

  2007cites this paper
• Time‐course of change in [11C]carfentanil and [11C]raclopride binding potential after a nonpharmacological challenge

  2007cites this paper
• Muscarinic Acetylcholine Receptors in the Central Nervous System: Structure, Function, and Pharmacology

  2007cites this paper
• Cysteinyl-Leukotriene Receptors and Cellular Signals

  2007influential citation
• Leukotrines and leukotriene receptors : Potential roles in cardiovascular diseases

  2007cites this paper
• Cocaine withdrawal enhances long‐term potentiation induced by corticotropin‐releasing factor at central amygdala glutamatergic synapses via CRF1, NMDA receptors and PKA

  2006cites this paper